Antigenic Respiratory Syncytial Virus Polypeptides
AssigneeSanofi
InventorsGary J. Nabel, Chih-Jen Wei, Kurt Swanson, Pradeep Dhal, Ram Dharanipragada, Magnus Besev
Life of this patent
Estimating the term…
Abstract
This disclosure relates to antigenic respiratory syncytial virus (RSV) polypeptides for use in eliciting antibodies against RSV. Also disclosed are antigenic polypeptides comprising an RSV polypeptide and a ferritin protein.
Claims20
-39. (canceled)
An antigenic respiratory syncytial virus (RSV) polypeptide comprising an RSV F polypeptide, wherein an asparagine of the RSV F polypeptide is glycosylated, thereby blocking an epitope of the RSV F polypeptide that is shared between pre-fusion RSV F and post-fusion RSV F, wherein the RSV F polypeptide comprises a sequence having at least 90% identity to amino acids 1-478 of SEQ ID NO:
- 17, and wherein the asparagine corresponds to position 288, 308, or 467 of SEQ ID NO:
- 17.
An antigenic RSV polypeptide comprising an RSV F polypeptide and a ferritin protein, wherein the ferritin protein comprises a mutation replacing a surface exposed amino acid with a cysteine, and wherein the RSV F polypeptide comprises a sequence having at least 90% identity to amino acids 1-478 of SEQ ID NO:
- 17.
An antigenic respiratory syncytial virus (RSV) polypeptide comprising a sequence having at least 90% identity to amino acids 1-478 of SEQ ID NO:
- 17.
Dependencies are inferred from the claim text.